ConductScience.org, home

Trial · NCT07216742

Registered outcomes41

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primarycumulative live birth rate12 monthscumulative live birth rate following vitrified-thawed, single-euploid blastocyst transfer(s)
SecondaryPositive pregnancy (serum β-human chorionic gonadotropin [hCG])10 +/-2 days after Embryo transfer
SecondaryClinical pregnancy (intrauterine gestational sac with fetal heartbeat)5 weeks ± 6 days post-embryo transfer
SecondaryOngoing pregnancy (intrauterine pregnancy with fetal heartbeat)10 weeks ± 6 days post-embryo transfer (ET)
SecondaryLive birth rate9 months after ET
SecondaryNumber of oocytes retrieved per stimulation cycle12-22 days after controlled ovarian stimulation start
SecondaryNumber of metaphase II (MII) oocytes retrieved12-22 days after controlled ovarian stimulation start
SecondaryFertilization rate (proportion of MII oocytes with normal fertilization)12-22 days after Controlled Ovarian stimulation start
SecondaryNumber of Day 5 blastocysts from oocyte retrievals from Period 1 and Period 212-22 days after controlled ovarian stimulation start
SecondaryTotal gonadotropin dose required per stimulation cycle12-20 days after start Controlled ovarian stimulation
SecondarySerum estradiol concentration on the day of ovulation trigger12-20 days after controlled ovarian stimulation start
SecondarySerum progesterone (P4) on Day 5 of stimulation5 days after start controlled ovarian stimulation
SecondarySerum Follicular Stimulation Hormone (FSH) level on stimulation day 1, pre-dose1 day of stimulation
SecondarySerum Luteinizing hormone (LH) level on stimulation day 1, pre-dose1 day of stimulation
SecondarySerum human Chorionic Gonadotropin (hCG) level on stimulation day 1, pre-dose1 day of stimulation
SecondaryFSH level on stimulation day 1, 1-4 hours post dose1 day of stimulation
SecondaryLH level on stimulation day 1, 1-4 hours post dose1 day of stimulation
SecondaryhCG level on stimulation day 1, 1-4 hours post dose1 day of stimulation
SecondaryFSH level on stimulation day 5After 5 day of stimulation
SecondaryLH level on stimulation day 5After 5 day of stimulation

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07216742/registered